In addition to androgens, SBP1 expression is also downregulated by estrogen treatment (17-β estradiol) in estrogen receptor (ER)-positive breast cancer cells, but not in ER-negative cells [52]. This evidence concerns the gene ESR1 and breast carcinoma.